XXE97U7Measurement of Infection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction, New Technology Group 7
- Billable / Specific Code
XXE97U7 is a billable ICD-10-PCS procedure code for Measurement of Infection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction, New Technology Group 7. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The root operation Measurement involves determining the level of a physiological or physical function at a point in time.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | X | New Technology |
| 2 | Body System | X | Physiological Systems |
| 3 | Operation | E | Measurement |
| 4 | BodyPart | 9 | Nose |
| 5 | Approach | 7 | Via Natural or Artificial Opening |
| 6 | Device/Substance/Technology | U | Infection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction |
| 7 | Qualifier | 7 | New Technology Group 7 |
Questions About XXE97U7
Is XXE97U7 a billable code?
Yes. XXE97U7 is a complete seven-character ICD-10-PCS code, specific enough to report Measurement of Infection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction, New Technology Group 7 on inpatient claims from October 1, 2025 through September 30, 2026.
What do the characters in XXE97U7 mean?
XXE97U7 breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character X is the Body System (Physiological Systems); the 3rd character E is the Operation (Measurement); the 4th character 9 is the BodyPart (Nose); the 5th character 7 is the Approach (Via Natural or Artificial Opening); the 6th character U is the Device/Substance/Technology (Infection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction); the 7th character 7 is the Qualifier (New Technology Group 7).
